HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$0.98
Day range
$0.95 - $1.09
Year range
$0.93 - $3.97
Market cap
19.69M USD
Avg Volume
29.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.08M | -60.54% |
Operating expense | 10.95M | -9.73% |
Net income | -10.88M | -29.64% |
Net profit margin | -353.92 | -228.56% |
Earnings per share | — | — |
EBITDA | -9.66M | -35.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.68M | -77.49% |
Total assets | 24.46M | -61.55% |
Total liabilities | 53.05M | 6.60% |
Total equity | -28.59M | — |
Shares outstanding | 20.55M | — |
Price to book | -0.70 | — |
Return on assets | -92.02% | — |
Return on capital | 452.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.88M | -29.64% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
233
